Qin Shuitao, Li Jianling, Wu Siying, Li Sen, Huang Jing, Yu Jie, Wei Chaoping, Wei Lixia, Zhu Shuangbei, Chen Shanshan, Chen Meilan
Department of Hypertension, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Front Endocrinol (Lausanne). 2025 Aug 11;16:1606182. doi: 10.3389/fendo.2025.1606182. eCollection 2025.
This study aimed to investigate the risk factors associated with renal impairment among patients diagnosed with primary aldosteronism (PA).
This study enrolled 147 PA patients who were initially classified into hypokalemic (n=56) and normokalemic (n=91) groups according to serum potassium levels, followed by subgroup stratification using combined adrenal venous sampling (AVS) and computed tomography (CT) diagnostic data. For comparison, 280 patients diagnosed with essential hypertension (EH) served as the control group. Data on general patient characteristics and biochemical markers from blood and urine samples were collected. The analysis involved comparing these indicators across groups and performing binary logistic regression to identify potential risk factors for renal damage.
When compared to the EH group, the PA group had lower serum potassium and heart rate ( < 0.05), but higher diabetes prevalence, standing plasma aldosterone concentration (PAC), serum sodium, albumin-to-creatinine ratio (ACR), and 24-hour urinary potassium excretion ( < 0.05). Among PA patients, the hypokalemic subgroup showed higher systolic/diastolic blood pressures, PAC, serum sodium, 24-hour urinary potassium, microalbumin, and ACR versus the normokalemic subgroup ( < 0.05). Compared with the IHA subgroup, the APA subgroup showed significantly higher standing PAC levels ( < 0.05). The classic APA subgroup exhibited elevated 24-hour urinary microprotein, ACR values, and hypokalemia prevalence relative to non-classic unilateral cases ( < 0.05). However, no significant differences emerged between unilateral and bilateral aldosterone secretion groups for serum potassium, PAC levels, or renal damage markers (>0.05). Hypokalemia (=3.027) and urinary potassium (=1.052) predicted proteinuria (<0.05).
This study demonstrates that renal impairment is more pronounced in PA patients than in those with EH. Notably, the classic APA subtype exhibits particularly severe damage, specifically manifested by elevated urinary microalbumin excretion. Furthermore, concomitant hypokalemia in PA patients is associated with more severe renal impairment. Hypokalemia and increased 24-hour urinary potassium excretion emerge as key risk factors for renal damage within this patient population.
本研究旨在调查原发性醛固酮增多症(PA)患者肾功能损害的相关危险因素。
本研究纳入了147例PA患者,最初根据血清钾水平分为低钾血症组(n = 56)和血钾正常组(n = 91),随后使用肾上腺静脉联合采样(AVS)和计算机断层扫描(CT)诊断数据进行亚组分层。作为对照,280例诊断为原发性高血压(EH)的患者作为对照组。收集患者的一般特征数据以及血液和尿液样本中的生化标志物数据。分析包括比较各组间的这些指标,并进行二元逻辑回归以确定肾损伤的潜在危险因素。
与EH组相比,PA组血清钾和心率较低(<0.05),但糖尿病患病率、站立位血浆醛固酮浓度(PAC)、血清钠、白蛋白与肌酐比值(ACR)和24小时尿钾排泄量较高(<0.05)。在PA患者中,低钾血症亚组的收缩压/舒张压、PAC、血清钠、24小时尿钾、微量白蛋白和ACR高于血钾正常亚组(<0.05)。与特发性醛固酮增多症(IHA)亚组相比,醛固酮瘤(APA)亚组的站立位PAC水平显著更高(<0.05)。经典APA亚组相对于非经典单侧病例,24小时尿微量蛋白、ACR值升高,低钾血症患病率更高(<0.05)。然而,单侧和双侧醛固酮分泌组在血清钾、PAC水平或肾损伤标志物方面无显著差异(>0.05)。低钾血症(=3.027)和尿钾(=1.052)可预测蛋白尿(<0.05)。
本研究表明,PA患者的肾功能损害比EH患者更明显。值得注意的是,经典APA亚型表现出特别严重的损害,具体表现为尿微量白蛋白排泄增加。此外,PA患者合并低钾血症与更严重的肾功能损害相关。低钾血症和24小时尿钾排泄增加是该患者群体肾损伤的关键危险因素。